News
The challenges of patient clinical trial access
According to patient and caregiver associations, patients and the public at large should be better informed about clinical trials. Danika Laberge, general manager of CATALIS Québec, brought this subject up for discussion during the annual Innovative Medicines Canada conference on June 18th.
Pharmaceutical Industry Invests in the Development of Early Clinical Research in Quebec
CATALIS’s public and private partners join forces to make Quebec a global leader in the conduct of early-stage clinical trials.
CATALIS and its partners mark International Clinical Trials Day
To mark International Clinical Trials Day, on May 20, 2019, we will recognize the commitment of all research professionals who believe in the importance of clinical trials in generating innovative treatments for Quebec’s patients and citizens.
CATALIS and the McPeak-Sirois Group collaborate to promote the growth of clinical research in Quebec
The two organizations are joining forces to maximize the human and economic benefits of clinical trials province-wide.
Pooling Quebec’s clinical research resources to provide better patient care
How to propel Quebec to global leadership in early clinical research? Dr. Marc Rivière, the new chair of the board of directors of CATALIS Quebec, shares his vision.
A new tool for monitoring clinical research performance in Quebec
CATALIS has announced the implementation of a new automated performance report that will allow public institutions in the health and social service network to more easily access their clinical research performance data.
Novartis and Roche join the CATALIS Initiative
Novartis and Roche Join the CATALIS Initiative Industry partnership will help establish Quebec as a global leader in early stage clinical research MONTREAL, February 6, 2019— The CATALIS initiative is proud to announce that pharmaceutical companies Novartis and Roche have joined its partner network. A mere two years after its creation, CATALIS Québec has succeeded in mobilizing Quebec’s key players
The CATALIS initiative celebrates new partners
The CATALIS initiative celebrates new partners Private and public funding provide essential support and highlight Quebec’s role in the field of early stage clinical trials BOSTON, June 5th, 2018 – A year following its launch at the BIO conference in 2017, the CATALIS initiative is today proud to announce the arrival of new partners, both financial and medical, which will further
Merck Canada provides financial and expert support to CATALIS
Progression of Quebec’s world-class Early Clinical Research Ecosystem Merck Canada provides financial and expert support to CATALIS MONTREAL, Quebec (May 9, 2018) – CATALIS is proud to announce that Merck Canada confirms financial and expert support for its early clinical research initiative. This support from Merck Canada contributes to the promotion of this world-class field of research in Quebec. “At
Successful start for CATALIS
Successful start for CATALIS: initiative gains momentum, strengthening interest in the life sciences ecosystem MONTRÉAL (Quebec), October 25, 2017 —CATALIS presented its five-year plan to their partners’ that will set in motion the initiative announced in the Quebec government’s 2017-2027 Québec Life Sciences Strategy. The mission of CATALIS Quebec Clinical Trials, formerly known as the Early Stage Clinical Trials (ESCT) initiative,